TB Diagnostic Technologies

· TB Diagnostic Technologies and Hospital Impact

• Medical Center A in Taipei transitioned to auramine-rhodamine staining from Ziehl-Neelsen staining by 2014, aiming to improve TB detection and patient isolation.
• Enhanced diagnostic sensitivity resulted in doubling the positive sputum smear rate from 22.8% to 48.1%, especially for non-cavitary lung lesions.
• The median duration of non-isolated infectiousness reduced significantly from 12.5 days to 3 days, and the total number of non-isolated infectious patient-days decreased by 69% from 2001 to 2014.
• Suggestion: Implement continuous training for healthcare staff on the latest TB diagnostic technologies to maintain high detection rates and reduce the time to isolation.

· Risk Factors and Control Measures in Healthcare Settings

• Inadequate ventilation and insufficient environmental cleaning in healthcare settings heighten TB transmission risks.
• Frequent healthcare visits are closely linked to increased TB incidence, necessitating robust infection control measures in high-traffic areas like internal medicine and family medicine.
• Suggestion: Prioritize the installation of germicidal ultraviolet systems and upgraded ventilation in outpatient areas to minimize airborne transmission.

· Epidemiological Insights and Trends

• TB incidence and related mortality have declined in younger populations (<20 and 20–50 years) in mainland China, reflecting effective control measures.
• However, SS- TB cases and mortality in the >50 age group remained high, indicating ongoing vulnerabilities.
• Suggestion: Develop targeted health campaigns and screening programs focused on the elderly to address the persistently high TB rates in this demographic.

· Regional and Systemic Challenges in Taiwan

• Increased Health System Delay (HSD) in diagnosing TB was noted between 2003 and 2008, influenced by factors such as patient’s age, gender, and the type of health facility visited.
• Eastern Taiwan showed shorter HSDs due to a higher concentration of TB-specialized providers, while medical centers experienced longer delays.
• Suggestion: Enhance the distribution and accessibility of specialized TB healthcare services across different regions to ensure timely diagnosis and treatment.

· Link Between TB and Chronic Conditions

• Tuberculosis is a significant risk factor for developing chronic obstructive pulmonary disease (COPD), with risks increasing due to delays in TB treatment initiation.
• Early diagnosis and timely treatment of TB are crucial to mitigate COPD risk.
• Suggestion: Strengthen the integration of TB and COPD management protocols to improve patient outcomes and reduce the incidence of COPD among former TB patients.

See also: https://lintblab.weebly.com

References:

1. Sun H-Y, Wang J-Y, Chen Y-C, Hsueh PR, Chen Y-H, Chuang Y-C, et al. (2020) Impact of introducing fluorescent microscopy on hospital tuberculosis control: A before-after study at a high caseload medical center in Taiwan. PLoS ONE 15(4): e0230067.
2. Pan, S.C., Chen, C.C., Chiang, Y.T., Chang, H.Y., Fang, C.T. and Lin, H.H., 2016. Health care visits as a risk factor for tuberculosis in Taiwan: a population-based case–control study. American journal of public health, 106(7), pp.1323-1328.
3. Liu, K.H., Xiao, Y.X. and Jou, R., 2024. Multidrug-resistant tuberculosis clusters and transmission in Taiwan: a population-based cohort study. Frontiers in Microbiology, 15, p.1439532.
4. Huang, F. and Bello, S.T., 2024. Spatiotemporal analysis of regional and age differences in tuberculosis prevalence in mainland China. Tropical Medicine & International Health, 29(9), pp.833-841.
5. Fu, H., Lin, HH., Hallett, T.B. et al. Explaining age disparities in tuberculosis burden in Taiwan: a modelling study. BMC Infect Dis 20, 191 (2020).
6. Chen, C.C., Chiang, C.Y., Pan, S.C., Wang, J.Y. and Lin, H.H., 2015. Health system delay among patients with tuberculosis in Taiwan: 2003–2010. BMC infectious diseases, 15, pp.1-9.
7. Lee C-H, Lee M-C, Lin H-H, Shu C-C, Wang J-Y, et al. (2012) Pulmonary Tuberculosis and Delay in Anti-Tuberculous Treatment Are Important Risk Factors for Chronic Obstructive Pulmonary Disease. PLoS ONE 7(5): e37978.

TBC 036

NCD Screening in TB Contact Tracing

Diabetes and TB Incidence

• Korea's National Health Insurance Data Analysis: Diabetic individuals exhibit a 48% increased risk of tuberculosis (TB).Risk escalates with diabetes duration; over 5 years of diabetes corresponds to a 57% heightened TB risk. Stronger diabetes-TB links observed in men and younger adults. Newly diagnosed diabetics with high fasting plasma glucose (FPG) levels face a 79% greater TB risk. See also: Lin TB Lab

TB Treatment Outcomes

• Study from Taiwan NHIRD (2002-2013): Post-TB treatment phases see elevated risks of diabetes, acute myocardial infarction (AMI), and stroke, especially with treatment durations of 7-12 months. Risks are influenced by age, gender, and pre-existing non-communicable diseases (NCDs).Emphasizes the need for vigilant monitoring for NCDs following TB treatment.

Latent TB in Type 1 Diabetes Patients

• Cross-Sectional Study in Dar es Salaam: 14.9% prevalence of latent TB among type 1 diabetes mellitus (T1DM) patients, with variations across developmental stages. Significant correlation found between uncontrolled HbA1c levels and higher latent TB prevalence.

Observational Challenges and Mendelian Randomization Insights

• Challenges in Diabetes and PTB Relationship Studies: Issues include reverse causality, confounding factors, and type differentiation (T1DM vs. T2DM).Poor glycemic control linked to increased TB risk; metabolic disturbances in T1DM enhance susceptibility to PTB.
• Mendelian Randomization Findings: Genetic studies suggest a link between T1DM and PTB, with correlations to higher HDL-C levels but no direct causal relationships with other T1DM-related traits.

TB and Non-Communicable Diseases in Myanmar

• Yangon, Myanmar Cross-Sectional Study: TB patients often exhibit behavioral risk factors like smoking and drinking more frequently than general population. Nutritional disparities show TB patients more likely to be underweight; significantly lower incidence of overweight/obesity. Higher diabetes prevalence among TB patients, with implications for integrated screening of NCDs during TB contact tracing.

Integration of NCD Screening in TB Contact Tracing

• Efficiency and Cost-Effectiveness: Incorporating NCD screening during TB contact investigations can identify undiagnosed conditions, improving early intervention and management. Highlights the necessity for community-wide screening initiatives, particularly for diabetes, to address the dual burden of TB and NCDs.

References:

1. Yoo JE, Kim D, Han K, Rhee SY, Shin DW, Lee H. Diabetes status and association with risk of tuberculosis among Korean adults. JAMA network open. 2021 Sep 1;4(9):e2126099.
2. Salindri, A.D., Wang, J.Y., Lin, H.H. and Magee, M.J., 2019. Post-tuberculosis incidence of diabetes, myocardial infarction, and stroke: retrospective cohort analysis of patients formerly treated for tuberculosis in Taiwan, 2002–2013. International Journal of Infectious Diseases, 84, pp.127-130.
3. Majaliwa, E.S., Muze, K., Godfrey, E., Byashalira, K., Mmbaga, B.T., Ramaiya, K. and Mfinanga, S.G., 2023. Latent tuberculosis in children and youth with type 1 diabetes mellitus in Dar es Salaam, Tanzania: a cross section survey. BMC Infectious Diseases, 23(1), p.740.
4. Jiang, Y., Zhang, W., Wei, M., Yin, D., Tang, Y., Jia, W., Wang, C., Guo, J., Li, A. and Gong, Y., 2024. Associations between type 1 diabetes and pulmonary tuberculosis: a bidirectional mendelian randomization study. Diabetology & Metabolic Syndrome, 16(1), pp.1-9.
5. Zayar, N.N., Chotipanvithayakul, R., Bjertness, E., Htet, A.S., Geater, A.F. and Chongsuvivatwong, V., 2023. Vulnerability of NCDs and Mediating Effect of Risk Behaviors Among Tuberculosis Patients and Their Household Contacts Compared to the General Population in the Yangon Region, Myanmar. International Journal of General Medicine, pp.5909-5920.
6. Hamada, Y., Lugendo, A., Ntshiqa, T., Kubeka, G., Lalashowi, J.M., Mwastaula, S., Ntshamane, K., Sabi, I., Wilson, S., Copas, A. and Velen, K., 2024. A pilot cross-sectional study of non-communicable diseases in TB household contacts. IJTLD OPEN, 1(4), pp.154-159.

TBC 035

Interaction between DM and TB exacerbates disease progression

Public Health Challenges and Epidemiology: Tuberculosis (TB) presents varying challenges across economic contexts. Rapid diagnosis and treatment are essential in regions with high TB prevalence to manage and prevent the disease, primarily through addressing the reactivation of latent TB infections (LTBI). In areas with lower incidence, TB tends to concentrate within high-risk groups, necessitating strategies tailored to local epidemiological patterns and social determinants. Additionally, understanding the demographic shifts towards older populations and the impact of diabetes mellitus (DM) on TB, including increased risk and poorer outcomes, is crucial.

Impact of Diabetes on Tuberculosis: Diabetes significantly increases the risk of developing active TB and affects treatment outcomes. The interaction between DM and TB exacerbates disease progression, with DM patients experiencing higher mycobacterial loads and unique lung lesions. This underscores the importance of integrated health strategies that simultaneously address both TB and DM, including enhanced screening and research into the transmission dynamics among these patients.

Study Insights and Special Populations:

• A study in metro Atlanta, Georgia (2016-2019) on HIV-negative adults with type 2 diabetes (T2DM) highlighted that LTBI was less prevalent in diabetic patients compared to controls. This suggests unique interplays between T2DM and LTBI, impacting screening and management approaches.
• The WHO emphasizes LTBI screening in populations with compromised immune systems, such as those undergoing dialysis or with chronic kidney disease (CKD), due to elevated TB risk.

Health Outcomes and Quality of Life in TB Survivors: TB survivors face considerable health challenges, including increased risks of TB recurrence and mortality. Chronic conditions such as respiratory diseases and cardiovascular issues are more prevalent among these individuals, leading to diminished quality of life and increased healthcare needs. Social and economic repercussions include stigma and financial hardship, emphasizing the need for comprehensive healthcare strategies that integrate TB care with broader health services to manage ongoing issues and improve life quality.

Epidemiological and Clinical Integration: The convergence of TB and DM epidemics, especially in regions like South-East Asia, the Western Pacific, and the Middle East, driven by rising rates of diabetes due to obesity and aging populations, calls for integrated public health responses. These should consider the compounded effects of both diseases on mortality, treatment failure, and relapse rates.

Advancements in Screening and Treatment: Advancements in technology and healthcare strategies, such as single-cell analysis and predictive modeling, hold promise for enhancing the understanding and management of TB-DM comorbidity. These tools can help in identifying new therapeutic targets and biomarkers, improving the precision of diagnostics and treatments.

Comprehensive Care for TB Survivors: Addressing the long-term health effects faced by TB survivors requires a multifaceted approach that includes lung function evaluations, pulmonary rehabilitation, and cardiovascular care. Economic support and social integration programs are also vital to mitigate the socio-economic impacts of TB on survivors and their families.

References:

1. Lee, P.H., Fu, H., Lee, M.R., Magee, M. and Lin, H.H., 2018. Tuberculosis and diabetes in low and moderate tuberculosis incidence countries. The International Journal of Tuberculosis and Lung Disease, 22(1), pp.7-16.
2. Salindri, A.D., Haw, J.S., Amere, G.A., Alese, J.T., Umpierrez, G.E. and Magee, M.J., 2021. Latent tuberculosis infection among patients with and without type-2 diabetes mellitus: results from a hospital case-control study in Atlanta. BMC Research Notes, 14(1), p.252.
3. Zhang, X., Chen, P. and Xu, G., 2022. Update of the mechanism and characteristics of tuberculosis in chronic kidney disease. Wiener klinische Wochenschrift, 134(13), pp.501-510.
4. Kaur, R., Egli, T., Paynter, J., Murphy, R., Perumal, L., Lee, A., Harrison, A., Christmas, T., Lewis, C. and Nisbet, M., 2023. Tuberculosis and diabetes: increased hospitalisations and mortality associated with renal impairment. Internal Medicine Journal, 53(9), pp.1588-1594.
5. Choi, H., Han, K., Jung, J.H., Park, S.H., Kim, S.H., Kang, H.K., Sohn, J.W., Shin, D.W. and Lee, H., 2023. Long-term mortality of tuberculosis survivors in Korea: a population-based longitudinal study. Clinical Infectious Diseases, 76(3), pp.e973-e981. See also: https://tbreadingnotes.blogspot.com/2024/07/non-communicable-diseases-in-tb.html
6. Dodd, P.J., Yuen, C.M., Jayasooriya, S.M., van der Zalm, M.M. and Seddon, J.A., 2021. Quantifying the global number of tuberculosis survivors: a modelling study. The Lancet Infectious Diseases, 21(7), pp.984-992.

TBC 033

How Diabetes Fuels Tuberculosis in Vulnerable Communities

· High Undiagnosed Diabetes Prevalence:

• Finding: Among surveyed individuals, 4.0% had undiagnosed diabetes, and 33.7% had prediabetes, highlighting a significant gap in awareness and early detection. See also: https://tbreadingnotes.blogspot.com/2024/07/modeling-social-environmental-and.html
• Plan: Implement widespread community-based screening campaigns with portable diagnostic tools to detect diabetes early, focusing on high-risk populations.

· Diabetes as a Risk Factor for Tuberculosis (TB):

• Finding: TB prevalence increased with diabetes severity, affecting 7.6% of diabetics compared to 4.1% of non-diabetics. Diabetes increased TB risk by 1.5 times. See also: https://lintblab.weebly.com/speeches-and-courses.html
• Plan: Integrate TB screening into diabetes clinics to identify co-infections early and promote collaboration between TB and diabetes management programs.

· TB Infection Linked to Socioeconomic Factors:

• Finding: TB infection rates were higher among individuals with lower education (11.3%) and larger households (10.4%), indicating socioeconomic disparities.
• Plan: Enhance TB education programs in low-income communities and provide targeted interventions, including improved ventilation in crowded living spaces.

· Severe Diabetes Increases TB Risk:

• Finding: Indicators such as insulin use, chronic kidney disease, and long-term diabetes significantly raised TB risk.
• Plan: Prioritize TB screening for patients with severe diabetes indicators during routine clinical visits to reduce undetected cases.

· Blood Glucose Levels and TB Risk Relationship:

• Finding: Fasting blood glucose levels below 100 mg/dL increased TB risk by 37%, likely due to malnutrition or liver dysfunction.
• Plan: Educate patients on balanced nutrition and ensure regular monitoring of glucose levels, particularly in high-risk populations.

· Latent TB Infection (LTBI) in High-Risk Groups:

• Finding: LTBI prevalence was 71% among household contacts of TB cases, with diabetics showing the highest rates (86.7%).
• Plan: Establish LTBI screening protocols for close contacts of TB patients, especially those with diabetes, and provide preventive therapy as appropriate.

· Poor TB Outcomes Among Diabetics:

• Finding: Diabetic TB patients had a 15-fold increased risk of poor outcomes, including death and treatment failure.
• Plan: Develop personalized treatment plans for diabetic TB patients and enhance follow-up care to reduce adverse outcomes.

· Impact of Diabetes on Drug-Resistant TB:

• Finding: Diabetics with drug-resistant TB (DR-TB) or multidrug-resistant TB (MDR-TB) were 1.56 to 1.57 times more likely to experience treatment failure.
• Plan: Introduce routine drug-susceptibility testing for diabetics with TB to ensure appropriate and effective treatment regimens.

· Geospatial Data Enhances TB Control:

• Finding: Spatial analysis improves understanding of TB transmission patterns and enables targeted interventions in high-risk areas.
• Plan: Integrate geospatial tools into TB surveillance systems to identify hotspots and deploy resources effectively in resource-constrained settings.

References:

1. Martinez, L., Zhu, L., Castellanos, M.E., Liu, Q., Chen, C., Hallowell, B.D. and Whalen, C.C., 2017. Glycemic control and the prevalence of tuberculosis infection: a population-based observational study. Clinical Infectious Diseases, 65(12), pp.2060-2068.
2. Kang, J.Y., Han, K., Lee, S.H. and Kim, M.K., 2023. Diabetes severity is strongly associated with the risk of active tuberculosis in people with type 2 diabetes: a nationwide cohort study with a 6-year follow-up. Respiratory Research, 24(1), pp.1-9.
3. Smith, A. G. C., Kempker, R. R., Wassie, L., Bobosha, K., Nizam, A., Gandhi, N. R., Auld, S. C., Magee, M. J., Blumberg, H. M., & Tuberculosis Research Unit: Role of Antigen Specific Responses in the Control of TB (TBRU-ASTRa) Study Group. (2022). The impact of diabetes and prediabetes on prevalence of Mycobacterium tuberculosis infection among household contacts of active tuberculosis cases in Ethiopia. Open Forum Infectious Diseases, 9(7), ofac323.
4. Adane, H.T., Howe, R.C., Wassie, L. and Magee, M.J., 2023. Diabetes mellitus is associated with an increased risk of unsuccessful treatment outcomes among drug-susceptible tuberculosis patients in Ethiopia: A prospective health facility-based study. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 31, p.100368.
5. Lin, H., Shin, S., Blaya, J.A., Zhang, Z., Cegielski, P., Contreras, C., Asencios, L., Bonilla, C., Bayona, J., Paciorek, C.J. and Cohen, T., 2011. Assessing spatiotemporal patterns of multidrug-resistant and drug-sensitive tuberculosis in a South American setting. Epidemiology & Infection, 139(11), pp.1784-1793.
6. Lin HH, Shin SS, Contreras C, Asencios L, Paciorek CJ, Cohen T. Use of spatial information to predict multidrug resistance in tuberculosis patients, Peru. Emerg Infect Dis. 2012 May;18(5):811-3. doi: 10.3201/eid1805.111467.
7. Xu, G., Hu, X., Lian, Y. and Li, X., 2023. Diabetes mellitus affects the treatment outcomes of drug-resistant tuberculosis: a systematic review and meta-analysis. BMC Infectious Diseases, 23(1), p.813.

TBC 031